RBC Capital Markets upgraded Wave Life Sciences (WAV) to outperform from sector perform, lauding the recent phase 1 results ...

Wolfe Research upgraded life sciences toolmaker Waters Corporation (WAT) to Outperform from Peer Perform on Wednesday, citing ...

Actively moving up the value chain toward drug discovery, development and digital therapeutics is key to sustaining the State ...

Over the past four years, private equity (PE) firms that invested in life science assets have faced a difficult reality.

He now feels Wave stock rates an outperform (buy, in other words), one full notch up from his previous sector perform (hold).

The latest update is out from Tiziana Life Sciences ( (TLSA) ).

Discover why Wave Life Sciences Ltd. is a high-risk, high-reward biotech with unique RNA therapies for AATD, obesity, and ...

Strategic leadership, scaling the talent pipeline and regulatory sandboxes are all key, but must be underpinned by digital ...

Scientists have discovered that complex life began evolving much earlier than traditional models suggested. Using an expanded ...

Anavex Life Sciences' Phase 2B/3 trial failed to achieve statistical significance on both primary endpoints. Read why I ...

We have an emerging new entrant in the increasingly crowded weight loss drug space.

Through the first three quarters of 2025, M&A activity overtook the entire 2024 total, according to Endpoints News. Editor and founder John Carroll wrote in October this might be the best time in 15 ...